Led by partner Peter Huber, an international team of global law firm Hogan Lovells advised Myriad Genetics on the reorganization of its international business operations. As part of the reorganization, Myriad Genetics has sold its EndoPredict business to Eurobio Scientific, a leading French group in the field of in vitro diagnostic medicine and life sciences.
The reorganization aims to better align Myriad’s resources with domestic opportunities while continuing to serve key partnerships with biopharmaceutical companies and patients outside the United States.
Myriad Genetics is a leading company in genetic testing and precision medicine. The company develops and offers genetic tests that help assess the risk of developing disease or disease progression and support treatment decisions in medical specialties where genetic insights can significantly improve patient care and reduce healthcare costs.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
